title: Reduced GABAergic inhibition of kidney-related PVN neurons in streptozotocin-treated type 1 diabetic mouse.
abstract: Activity of presympathetic neurons in the paraventricular nucleus (PVN) of the hypothalamus is known to play an important role in the regulation of sympathetic outflow. Sympathetic overactivity is associated with many pathophysiological conditions such as diabetes mellitus and hypertension; however, the underlying synaptic mechanisms are poorly understood. In this study, we examined the GABAergic inhibitory synaptic control of kidney-related presympathetic PVN neurons in the streptozotocin-treated type 1 diabetic mouse model, using patch-clamp slice electrophysiology in combination with retrograde labeling. Type 1 diabetes resulted in decreased frequency of miniature inhibitory postsynaptic currents (mIPSCs). Our data also demonstrated a reduction of mIPSC amplitude and mean inhibitory current without alteration of input resistance. Furthermore, our data revealed decreased tonic GABAergic inhibition of kidney-related PVN neurons in diabetic conditions, which was consistent with the observed increased excitability of the presympathetic PVN neurons. In summary, our data demonstrated decreased phasic and tonic inhibitory control of kidney-related presympathetic PVN neurons that suggest altered sympathetic circuitry in type 1 diabetes.
authors: Neuroscience Program, School of Science and Engineering, Tulane University, New Orleans, Louisiana; and.
authors: Yanyan
authors: Y
authors: Jiang
authors: Hong
authors: H
authors: Gao
authors: Amanda M
authors: AM
authors: Krantz
authors: Andrei V
authors: AV
authors: Derbenev
authors: Andrea
authors: A
authors: Zsombok
mesh_terms: D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000503:physiopathology*; D018756:GABA Antagonists / Q000494:pharmacology; D059330:GABAergic Neurons / Q000187:drug effects / Q000502:physiology*; D053444:Inhibitory Postsynaptic Potentials; D007668:Kidney / Q000294:innervation; D008297:Male; D051379:Mice; D055369:Miniature Postsynaptic Potentials; D010286:Paraventricular Hypothalamic Nucleus / Q000166:cytology / Q000503:physiopathology*
chemical_list: D018756:GABA Antagonists
keywords: paraventricular nucleus; patch clamp; presympathetic neurons; pseudorabies virus; type 1 diabetes
references: Nebr Med J. 1996 Dec;81(12):419-23
references: 9046793
references: Biochim Biophys Acta. 2010 Apr;1802(4):416-31
references: 20060897
references: Neurosci Lett. 2010 May 3;474(3):168-172
references: 20303390
references: J Neurosci. 1995 Apr;15(4):2948-60
references: 7722639
references: J Neurosci. 2002 Apr 1;22(7):2701-10
references: 11923435
references: Cancer Res. 1968 Aug;28(8):1501-6
references: 4299824
references: Endocrinology. 2006 Aug;147(8):3746-60
references: 16675519
references: J Auton Nerv Syst. 1998 Mar 3;69(1):21-30
references: 9672120
references: J Neurosci. 2000 Feb 1;20(3):937-48
references: 10648698
references: J Physiol. 2007 Jul 15;582(Pt 2):539-51
references: 17495040
references: Nat Neurosci. 2003 May;6(5):484-90
references: 12679782
references: Diabetes. 2012 Jun;61(6):1381-90
references: 22492526
references: J Physiol. 2001 Oct 1;536(Pt 1):141-52
references: 11579164
references: Neuroscience. 2012 Sep 6;219:48-61
references: 22698695
references: Am J Physiol Regul Integr Comp Physiol. 2012 Oct 15;303(8):R807-14
references: 22914748
references: Am J Physiol. 1993 Nov;265(5 Pt 2):H1727-33
references: 8238586
references: J Neurophysiol. 2010 Jan;103(1):4-15
references: 19889858
references: Am J Physiol Heart Circ Physiol. 2006 Mar;290(3):H1110-9
references: 16243912
references: Am J Physiol. 1991 Sep;261(3 Pt 2):H860-7
references: 1887930
references: J Physiol. 2001 Nov 15;537(Pt 1):161-77
references: 11711570
references: J Neurophysiol. 2011 Sep;106(3):1545-57
references: 21697450
references: Annu Rev Neurosci. 1983;6:269-324
references: 6132586
references: J Neurosci. 2011 Sep 28;31(39):14024-31
references: 21957263
references: Hypertension. 1989 Aug;14(2):177-83
references: 2759678
references: Clin Exp Hypertens. 2001 Jan-Feb;23(1-2):45-55
references: 11270588
references: Hypertension. 1991 Jul;18(1):48-55
references: 1860711
references: Trends Neurosci. 2004 May;27(5):262-9
references: 15111008
references: Am J Physiol Regul Integr Comp Physiol. 2003 Nov;285(5):R1231-9
references: 12881200
references: Brain Res. 1985 Mar 11;329(1-2):205-12
references: 3978442
references: J Neurosci. 1993 Jun;13(6):2515-39
references: 8388923
references: Ann N Y Acad Sci. 2001 Jun;940:431-43
references: 11458699
references: J Neurophysiol. 2010 Feb;103(2):904-14
references: 20018836
references: J Neurosci. 1998 Mar 1;18(5):1693-703
references: 9464994
references: J Pharmacol Exp Ther. 2007 Feb;320(2):615-26
references: 17071818
references: Diabetes Care. 2003 Nov;26(11):3035-41
references: 14578236
references: News Physiol Sci. 2001 Dec;16:266-71
references: 11719602
references: Anat Rec A Discov Mol Cell Evol Biol. 2004 Sep;280(1):808-20
references: 15382020
references: Brain Res. 1991 Mar 15;543(2):296-300
references: 1676330
references: Science. 1976 Jul 30;193(4251):415-7
references: 180605
references: Diabetes Care. 1994 Jun;17(6):578-84
references: 8082528
references: J Neurophysiol. 2002 May;87(5):2624-8
references: 11976398
references: J Comp Neurol. 2004 Apr 12;471(4):462-81
references: 15022264
references: J Physiol. 2007 Mar 15;579(Pt 3):849-61
references: 17218355
references: Hypertension. 2003 Dec;42(6):1124-9
references: 14597646
references: Nat Med. 2009 Dec;15(12):1407-13
references: 19915593
references: J Physiol. 2000 Feb 15;523 Pt 1:193-209
references: 10673555
references: J Physiol. 1996 Dec 15;497 ( Pt 3):753-9
references: 9003560
references: Am J Physiol Regul Integr Comp Physiol. 2010 Jul;299(1):R129-39
references: 20164200
references: Naunyn Schmiedebergs Arch Pharmacol. 1983 May;322(4):290-4
references: 6346111
references: Am J Physiol Regul Integr Comp Physiol. 2007 Mar;292(3):R1184-9
references: 17122330
references: J Neurophysiol. 2012 May;107(10):2912-21
references: 22357793
references: Eur J Neurosci. 2008 Jun;27(12):3226-32
references: 18554298
references: J Neurophysiol. 1997 Jun;77(6):3396-400
references: 9212285
references: J Neuroendocrinol. 2002 Dec;14(12):929-32
references: 12472873
references: PLoS Pathog. 2009 Oct;5(10):e1000640
references: 19876391
references: Diabetes Care. 1999 Jul;22(7):1151-7
references: 10388981
references: Mol Pharmacol. 2008 Mar;73(3):995-1004
references: 18089839
references: J Comp Neurol. 2011 May 1;519(7):1301-19
references: 21452198
references: Brain Res. 1984 Sep 24;310(2):355-9
references: 6488025
references: Kidney Int. 2012 Aug;82(3):292-303
references: 22475818
references: J Hypertens. 2007 May;25(5):909-20
references: 17414649
references: J Physiol. 2009 Oct 1;587(Pt 19):4645-60
references: 19703969
references: Acta Physiol Scand. 2003 Jan;177(1):17-26
references: 12492775
references: Hypertension. 1982 Jul-Aug;4(4):556-65
references: 6218080
references: J Chem Neuroanat. 2009 Nov;38(3):197-208
references: 19778682
references: Am J Physiol. 1998 Sep;275(3):R728-34
references: 9728069
references: Physiol Rev. 1994 Apr;74(2):323-64
references: 8171117
references: Neuroendocrinology. 1980 Dec;31(6):410-7
references: 6109264
references: Proc Soc Exp Biol Med. 1995 Mar;208(3):300-6
references: 7878070
references: Mol Pharmacol. 2003 Jan;63(1):2-8
references: 12488530
references: Am J Physiol Heart Circ Physiol. 2003 May;284(5):H1710-20
references: 12521941
references: J Comp Neurol. 2003 Sep 29;464(4):525-39
references: 12900922
references: Brain Res. 1999 Oct 16;845(1):77-91
references: 10529446
references: Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):9264-9
references: 10922076
references: J Physiol. 2006 Feb 1;570(Pt 3):469-84
references: 16284073
references: Circulation. 2003 May 6;107(17):2190-5
references: 12695289
references: J Neurosci. 1996 Nov 15;16(22):7151-60
references: 8929424
references: Hypertension. 2007 Apr;49(4):916-25
references: 17309953
references: J Physiol. 2007 Mar 15;579(Pt 3):691-702
references: 17218356